DB05752ExperimentalSmall molecule
ALKS 27 is an inhaled formulation of trospium chloride for the treatment of chronic obstructive pulmonary disease (COPD). Study showed that ALKS 27 was well-tolerated over a wide dose range,...
- Mechanism
- Curator reviewed
ALKS 27 is a muscarinic receptor antagonist that relaxes smooth muscle tissue and has the potential to improve airflow in patients with chronic obstructive pulmonary disease (COPD).
- Primary indication
- Investigated for use/treatment in chronic obstructive pulmonary disease (COPD).Curator reviewed
- Code names
- ALKS 27
Resolves to
What you can answer from here — as of April 02, 2025
5Protein targetsEach mapped to UniProt, with action and pharmacological actionListed above
Which drugs share a target with ALKS 27, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account